Health Optimization Medicine
The Precision Health Report
Updates from the world of health optimization medicine
The Archive29 issues
Tuesday, July 21, 2026Vol. I, No. 29
July 21, 2026
A focused edition by design, because the strongest verified findings this cycle all circle one idea: biological age is a single readable number, and the inputs that move it are whole and lived, not isolated and swallowed. A rigorous two-year trial shows a fish oil supplement doing nothing for the aging brain even after it was proven to reach brain tissue, while a large cohort finds that a lived behavior, regular cultural engagement, tracks with a physiological age about three years younger and rivals exercise for effect size. A single protein turns out to act as an evolved brake on aging muscle repair, trading speed for survival, and a spatial map reads the biological age of the human lung and finds failing mitochondria at the center of it. Chronobiology, the gut-immune system, and epigenetics had no fresh standalone signal that cleared the bar this window, so this is a lighter, four-pillar issue built around the findings that did.
Read the full issue →
Monday, July 20, 2026Vol. I, No. 28
July 20, 2026
A focused edition built around one idea: food is information, not just fuel, and the sweeteners we treat as free are not inert at all. Two fresh studies this week make the point from opposite organs. A large human cohort ties higher intake of common sugar substitutes to a measurably faster-aging brain, and a Cambridge lab shows those same sweeteners directly bend the growth of gut bacteria, with the damage amplified when they ride along with an everyday drug. On the other side of the food-quality line, a whole-food Mediterranean pattern raises two protective signals made inside the mitochondria, and a separate finding reads reproductive aging as a specific, modifiable molecular program. Clinical metabolomics, chronobiology, and epigenetics had no fresh standalone signal that cleared the bar this window, so this is a lighter, four-pillar issue by design.
Read the full issue →
Sunday, July 19, 2026Vol. I, No. 27
July 19, 2026
Four verified findings this cycle circle one idea: the pace of aging is a single, readable thing, and wildly different inputs move it. A weight-loss drug slows a person's whole-body aging clock across several organ systems at once. A lifetime of exercise keeps muscle's energy machinery young and delays its molecular aging. A single gut bacterium turns an amino acid into a signal that sharpens the immune system's attack on a tumor. And in midlife, the blood's chemical profile connects the way a person lives to how their brain will hold up years before any diagnosis. The chronobiology, exposomics, and evolutionary pillars had no fresh standalone signal that cleared the bar this window, so this is a four-pillar issue built around the findings that did.
Read the full issue →
Friday, July 17, 2026Vol. I, No. 26
July 17, 2026
A focused edition by design, because only two findings this cycle cleared the bar as fresh, verifiable, and not already covered, and both tell the same story: precision subtraction, targeting the single broken element and sparing the healthy network around it. A phage therapy disarms the specific gut bacteria that drive Crohn's inflammation without carpet-bombing the rest of the microbiome. And a spatial map of the aging brain shows senescent immune cells clustered in one patch of white matter that can be cleared selectively while healthy glia are spared. The other five pillars had no fresh standalone signal that cleared the bar this window (the metabolomics items were either already covered here or were additional aging clocks that rhyme with recent issues), so this is a lighter, two-pillar issue built around the findings that did.
Read the full issue →
Tuesday, July 14, 2026Vol. I, No. 25
July 14, 2026
A leaner edition by design, because only one finding this cycle was fresh within the last seven days, and the strongest verified items all circle the same idea: nutrients and metabolites act as signals, and health turns on how a molecule is delivered and read, not simply on whether it is present. Gut microbes hand-deliver vitamin A to the immune cells that build a body's defenses. A single blood sugar reading looks, on causal grounds, like an accelerator of brain aging. A whole-exposome atlas ranks vitamin E and blood lipids among the loudest inputs into health. And a two-year trial shows a plain daily multivitamin nudging the epigenetic clock. Chronobiology, evolutionary medicine, and mitochondrial bioenergetics had no fresh standalone signal that cleared the bar, so this is a slightly lighter issue built around the four pillars that did.
Read the full issue →
Monday, July 13, 2026Vol. I, No. 24
July 13, 2026
Four verified findings this cycle circle one idea: aging is silent and asynchronous, running for years inside specific cells and tissues before any disease shows up, and it is readable and interruptible long before then. A Stanford team reads the biological age of more than 40 cell types from a single blood draw. A Swedish cohort spots type 2 diabetes in the gut years ahead of diagnosis. An Italian group switches off the telomere alarm that drives senescence and restores a failing blood system. And a network-medicine map lays 6,442 existing drugs over the hallmarks of aging to see which ones push the clock backward. The chronobiology, exposomics, and mitochondrial pillars had no fresh standalone signal that cleared the bar, so this is a slightly leaner edition by design, built around the four that did.
Read the full issue →
Thursday, July 9, 2026Vol. I, No. 23
July 9, 2026
A leaner, focused edition by design, because the tight seven-day window turned up only a handful of findings that were fresh, verifiable, and not already covered, and the strongest ones all circle the same idea. Biological age is a number you can read and, at specific pathways, move, and it comes apart from the calendar in both directions. Centenarians carry a distinct metabolomic fingerprint that reads younger than their years, a nutrient-sensing drug lowers the DNA damage that ages immune cells, bright light at night speeds metabolic aging, and living at high altitude accelerates aging across the gut, the epigenome, and the metabolism at once. Chronological time is fixed. The pace of aging is set by inputs you can measure.
Read the full issue →
Saturday, June 27, 2026Vol. I, No. 22
June 27, 2026
A lighter, focused edition by design, because only a few findings this cycle cleared the bar for fresh, verifiable, and not already covered. The ones that did all circle the same idea: the inputs we treat as 'enough' are usually set to avoid deficiency or disease, not to keep a body optimal, and aging muscle and its energy machinery pay the difference. A garlic-derived molecule turns out to raise a measurable blood enzyme that feeds NAD+ and supports muscle in aged animals, a new review argues that the protein and exercise floors are aimed at preventing deficiency rather than preserving strength and independence, and the humble B12 story turns out to be a mitochondrial one. The through-line is the gap between survival ranges and optimal ranges, which is the whole point of this specialty.
Read the full issue →
Friday, June 26, 2026Vol. I, No. 21
June 26, 2026
Three genuinely fresh findings this cycle, plus one strong recent one, circle the same idea from different angles: the decline we lump together as "aging" is a set of processes, and several of them are separable from the calendar. A tropical butterfly evolved a longer life with little physical decline, a cell-biology paper shows that one exportable molecular step drives the inflammation of old cells and can be blocked, and two human studies remind us that the inputs tilting that trajectory, a vitamin level and a buried chemical exposure, are usually invisible unless we measure them. The through-line is salutogenic and practical: slowed decline is biologically real, and the levers on it are often things we never bother to read.
Read the full issue →
Wednesday, June 24, 2026Vol. I, No. 20
June 24, 2026
A leaner edition by design, built around two genuinely fresh findings plus two strong recent ones that all point at the same dial: chronic, low-grade inflammation, the body's cell danger response left running too hot. A study of long-lived families found a rare variant in a DNA-sensing immune gene that quietly turns the inflammatory alarm down, and the offspring of long-lived parents developed cardiometabolic disease about 13 years later. A mouse study shows that eating at the wrong time of day knocks the gut's own cell-clocks out of sync, including the clock in its resident immune cells. Two supporting items, honestly older, rhyme with the theme: a human trial where a gut microbe reinforced the intestinal barrier and held weight off after dieting, and a large genetic analysis tying a single blood amino acid to a shorter male lifespan through an inflammatory, insulin-resistant route. Different doors, one room.
Read the full issue →
Monday, June 22, 2026Vol. I, No. 19
June 22, 2026
A lighter, focused edition by design, because only two findings this cycle cleared the bar for fresh, verifiable, and not-already-covered. They happen to rhyme. A large biomarker study shows that "eat your five a day" does not get most people to the level of flavanols actually tied to a lower risk of dying from heart disease, because the specific foods matter far more than the total. And a preclinical study identifies an endogenous molecule, made by a gene the diseased brain quietly switches off, that reprograms the brain's immune cells back to a protective state. The through-line is specificity: health turns on particular bioactive molecules, the right ones present at the right level, not on broad food groups or generic "clearance."
Read the full issue →
Sunday, June 21, 2026Vol. I, No. 18
June 21, 2026
A focused Sunday edition by design, built around four verified findings that rhyme. Three of them say the same thing from different doors: the body keeps records of its own state, and those records are not passive bystanders, they are causal and they are personal. A rare progeria syndrome shows that age-related DNA hypermethylation can actively drive tissue decline rather than just mark it. A large study makes a hidden metabolic set-point, insulin resistance, readable from a smartwatch and a routine blood draw. A randomized trial shows that timing exercise to a person's own body clock beats generic timing. And the honest counterweight, more than 5,000 mother-child pairs, shows the exposome writing itself across the lifecycle into the next generation. The through-line is precision: read this person's clock, this person's methylome, this person's metabolism, then act.
Read the full issue →
Friday, June 19, 2026Vol. I, No. 17
June 19, 2026
A leaner edition by design, built around three genuinely fresh findings from this week plus one strong human trial. Two of the week's standout papers, both in mice, tell the same salutogenic story from different tissues: the body's machinery for rebuilding and for cleaning up after itself is not gone with age, it is switched off or stalled, and it can be turned back on. The honest counterweight is a perspective piece on nutritional dark matter, a reminder that we have mapped only a sliver of the inputs feeding those systems. The through-line is restoration over replacement, and the one move you can use today comes not from a drug but from the clock.
Read the full issue →
Thursday, June 18, 2026Vol. I, No. 16
June 18, 2026
A lighter, focused edition by design, because only two findings this cycle cleared the bar for fresh and verifiable, and they happen to push against the same lazy reflex. A reanalysis of two landmark prevention trials shows that prediabetes only protects the heart when blood sugar actually returns to a normal range, not when a patient merely tries. And a mouse study finds that different kinds of exercise reshape the gut microbiome and the blood metabolome in different ways, so the type of work changes the systemic result. The shared lesson is that the metabolic network rewards specificity and a state you actually reach, not generic effort.
Read the full issue →
Wednesday, June 17, 2026Vol. I, No. 15
June 17, 2026
A themed edition by design, because this cycle's strongest verified findings all point at one lever. A brain-imaging paper in PLOS Biology and a wave of reports from ENDO 2026, the year's largest endocrine meeting, converge on the metabolic axis (insulin, glucose, BMI, and blood lipids) as the upstream driver of outcomes in tissues far from the pancreas: the brain, the gonads, the gut, and bone. Several pillars are quiet today on purpose, because the real signal clustered in one place and forcing the rest would only dilute it.
Read the full issue →
Tuesday, June 16, 2026Vol. I, No. 14
June 16, 2026
A focused edition by design, because three of this cycle's strongest findings tell one story: the supplement aisle took three hits at once. A "focus" amino acid tracked with a shorter lifespan in men, blanket calcium and vitamin D did almost nothing for fractures or falls across 154,000 people, and omega-3 capsules tracked with faster cognitive decline through brain energy metabolism rather than amyloid. None of this says nutrients do not matter. It says a pill helps only when it corrects a measured deficit toward an optimal range, and that more is not better.
Read the full issue →
Monday, June 15, 2026Vol. I, No. 13
June 15, 2026
A quieter, focused edition by design, built around four verified findings and one strong idea. Two of them say the same hopeful thing from different tissues: the brain and the mitochondria both kept the capacity to rebuild deep into old age, and in both studies the people who started in the worst shape gained the most. The counterweight is the exposome. A persistent "forever chemical" is now raining down worldwide, including from the gases we chose to replace CFCs, which is a reminder that some inputs are systemic, not personal. Build what is trainable, reduce what you can.
Read the full issue →
Sunday, June 14, 2026Vol. I, No. 12
June 14, 2026
This cycle is about inputs: what you breathe, what you eat, and what you swallow as a supplement, and how clearly each one writes itself into cognition and biological age. The recurring surprise cuts against the reflex that more or newer is better. A popular joint supplement tracked with faster Alzheimer's progression, ultra-processed food dulled attention even in otherwise healthy eaters, and the diet that rolled back biological-age markers the most was a plain one. Read the input, measure the output, and stop assuming.
Read the full issue →
Saturday, June 13, 2026Vol. I, No. 11
June 13, 2026
The aging brain keeps showing up this cycle as something written from the outside in, by immune cells, by the gut, by the clock, and by what we ask the body to do. Four of today's signals describe brain aging as an immune and metabolic readout, and several of them bent backward when the inputs changed. The quiet second theme is dose: the benefit of resistance training peaked near two hours a week, which rhymes with a new metabolomic clock built on optimal levels rather than maxima. More is not the goal. Right is.
Read the full issue →
Friday, June 12, 2026Vol. I, No. 10
June 12, 2026
One genuinely fresh standout anchors this issue: a Nature Communications paper showing that a single membrane lipid, phosphatidylcholine, falls with age and drags mitochondrial flexibility down with it, and that feeding the precursor reverses the damage. Read alongside a new blood metabolomics aging clock and the latest pace-of-aging data, the week's signal is the same in three places. Biological aging is becoming both readable and, in part, reversible, and the thing we are reading is metabolic flexibility, not disease.
Read the full issue →
Thursday, June 11, 2026Vol. I, No. 9
June 11, 2026
A clear theme runs through this cycle: health is coordination, not a single switch. From a fresh evolutionary-medicine reframing of the growth-versus-maintenance axis, to mitochondrial NAD+ deciding whether a cell stays calm or sounds the alarm, to gut butyrate tuning antibody production, the strongest signals this week describe systems talking to each other. A new Aging-US editorial says the quiet part out loud: durable healthspan will come from coordinated layers across the life course, not from any one miracle target.
Read the full issue →
Wednesday, June 10, 2026Vol. I, No. 8
June 10, 2026
A lighter, themed edition by design. Two genuinely fresh findings this cycle (both reported June 8) point at the same target from opposite ends of the cell: a dietary and drinking-water exposure that raises dementia risk, and a mitochondrial mechanism that drives Alzheimer's from inside the neuron. Around them sit three strong, slightly older signals that all describe one thing: the aging brain and the aging immune system are now measurable, and in places, modifiable.
Read the full issue →
Tuesday, June 9, 2026Vol. I, No. 7
June 9, 2026
Two findings this cycle describe the same idea from opposite ends: your biological age is being written by your environment, and it is measurable. Microplastics turned up in every human bile sample tested and aged the cells lining the bile ducts, while a new microbiome "clock" reads biological age from gut bacteria and the variety of nutrients in your diet. One is the damage, the other is the dial.
Read the full issue →
Monday, June 8, 2026Vol. I, No. 6
June 8, 2026
A lighter cycle, and we will not pad it. The one finding worth your attention is a clean human signal that a common "forever chemical" measurably weakens the adult immune response, with a dietary counterpoint on how omega-3-derived lipid mediators help the body resolve inflammation and recover. Today's theme: the immune system is a report card on your exposome and your diet.
Read the full issue →
Sunday, June 7, 2026Vol. I, No. 5
June 7, 2026
This cycle points at a single molecule wearing two faces: mitochondrial DNA. When mitochondria are damaged, their DNA leaks into the cell, where an ancient surveillance system (cGAS-STING) mistakes it for an invader and lights the inflammatory fuse. That is the molecular grammar of the Cell Danger Response, and today's findings show the upstream stressors that feed it (a weak body clock, inhaled microplastics) and one gut-side lever that damps it.
Read the full issue →
Saturday, June 6, 2026Vol. I, No. 4
June 6, 2026
This cycle has one quiet protagonist: inflammaging, the chronic, low-grade inflammation that accumulates as the body ages. Four of today's findings are views of the same fire from different angles: Klotho restrains it and tracks slower biological aging, artificial light at night stokes it in the airway and the artery, fermented foods damp it across nineteen cytokines, and a longitudinal epigenetic clock reads its cumulative toll well enough to predict death. The through-line is that inflammaging is not a vague backdrop, it is measurable, modifiable, and networked.
Read the full issue →
Friday, June 5, 2026Vol. I, No. 3
June 5, 2026
This is a reality-check cycle. Three independent human studies this window puncture popular optimization shortcuts: isocaloric time-restricted eating shifts the circadian clock but yields no cardiometabolic benefit, NAD+ precursors raise blood NAD+ partly by feeding gut microbes rather than acting as a clean tissue "boost," and weight-loss-driven changes in epigenetic age fail to track the cardiometabolic improvements they supposedly index. The through-line is the most HOMe lesson there is: measure the outcome, do not assume the mechanism.
Read the full issue →
Thursday, June 4, 2026Vol. I, No. 2
June 4, 2026
Yesterday's cycle traced how the exposome traps cells in the Cell Danger Response; today's signal is the rebuttal, the network is measurably reversible. A May 29 systematic review catalogs the human interventions that actually lower next-generation epigenetic clocks, a phase-1 RCT shows a mitophagy-inducing bioidentical rejuvenating immune aging, and a June 3 review reframes meal timing as a cardiometabolic lever independent of diet content. The through-line is salutogenesis with a number attached.
Read the full issue →
Wednesday, June 3, 2026Vol. I, No. 1
June 3, 2026
This cycle's signal is a single mechanism wearing seven masks. A May 22 mini-review maps how microplastics and nanoplastics drive mitochondrial ROS, regulated cell death, and immune exhaustion, the exposome speaking directly to the mitochondrion, while a parallel human study shows the same particles remodeling the gut holobiont. Read together, they are a near-textbook rendering of the Cell Danger Response (CDR), the stuck-defense state that ties exposomics, mitochondrial bioenergetics, and the gut-immune system into one loop.
Read the full issue →
The Precision Health Report
The science of optimizing your biology, sourced and translated, with no hype. A weekly report from Dr. Tagge.
Get the weekly report
From the practice
Written for fellow practitioners. If you are reading as a patient, this is the same evidence I work from in the clinic.